Pritmohinder S Gill

Title: Pritmohinder S Gill: Innovator in Acetaminophen Research

Introduction

Pritmohinder S Gill is a notable inventor based in Little Rock, AR (US). He has made significant contributions to the field of acetaminophen research, particularly in understanding its toxicity and developing methods for diagnosis.

Latest Patents

Pritmohinder S Gill holds 2 patents. His latest patents include "Acetaminophen adducts and methods of use thereof." This disclosure relates to acetaminophen protein adducts and methods for diagnosing acetaminophen toxicity using these adducts. The present disclosure provides acetaminophen (APAP)-protein adducts and methods for detecting acetaminophen-induced toxicity in a subject. One aspect of this disclosure includes an APAP-protein adduct for diagnosing acetaminophen-induced toxicity. The inventors have identified proteins modified by N-acetyl-pbenzoquinoneimine (NAPQI) in subjects with acetaminophen-induced toxicity. Non-limiting examples of proteins modified by NAPQI include betaine-homocysteine S-methyltransferase 1, cytoplasmic aspartate aminotransferase, 1,4-alpha-glucan branching enzyme, formimidoyltransferase-cyclodeaminase, and dystrophin.

Career Highlights

Throughout his career, Pritmohinder S Gill has worked with various organizations, including Bioventures, LLC and Arkansas Children's Hospital Research Institute, Inc. His work has focused on advancing the understanding of acetaminophen's effects and improving diagnostic methods.

Collaborations

Pritmohinder S Gill has collaborated with notable colleagues, including Laura James and Jack Hinson. These collaborations have contributed to the advancement of research in his field.

Conclusion

Pritmohinder S Gill's innovative work in acetaminophen research has led to significant advancements in understanding its toxicity and developing diagnostic methods. His contributions continue to impact the medical field positively.